Matthew Kent is a partner in the firm’s Litigation & Trial Practice Group who specializes in antitrust litigation, counseling and other complex litigation. Matthew has extensive experience prosecuting and defending global price-fixing cartels for Fortune 100 companies.
He has defended pharmaceutical companies in private litigation and government investigations of so-called “reverse payment” settlement agreements. He also regularly advises clients on antitrust issues related to joint ventures and mergers and acquisitions, including filings under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and international premerger notification regimes.
Matthew has assisted clients with merger reviews by the U.S. Department of Justice, Federal Trade Commission and foreign competition authorities. He also provides ongoing antitrust counseling to clients on: distribution policies, exclusionary business practices, intellectual property licensing, competitor collaborations, group purchasing and standard setting.
Matthew has been recognized for his antitrust law expertise by Georgia Super Lawyers. He serves as the chair of the Business Torts and Civil RICO Committee of the American Bar Association’s (ABA) Section of Antitrust Law. He is active in the State Bar of Georgia’s Antitrust Section and writes regularly on antitrust topics.
Georgia State University (J.D., 2007)
Mercer University (M.B.A., 2004)
University of Georgia (B.B.A., 2003)
Bar Admissions : Georgia
ABA Section of Antitrust Law, Unilateral Conduct Committee, co-chair
ABA Section of Antitrust Law, Business Torts & Civil RICO Committee, chair (2014-17)
ABA Section of Antitrust Law, Ethics & Compliance Committee, vice-chair (2011-14)